Ohcanbohtosat - Jean‐Jacques Grob
- Čájehuvvo 1 - 20 / 107
- Sirdás čuovvovaš siidui
-
1
Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: A randomized study Dahkki Sophie Girardi, C. Gaudy, Joanny Gouvernet, Jacques Teston, M.‐A. Richard, Jean‐Jacques Grob
Almmustuhtton 2005Artigo -
2
Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma Dahkki F. Albarel, C. Gaudy, Frédéric Castinetti, T. Carré, Isabelle Morange, B. Conte‐Devolx, Jean‐Jacques Grob, Thierry Brue
Almmustuhtton 2014Artigo -
3
Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes Dahkki C. Gaudy, C. Clévy, S. Monestier, Noémie Dubois, Yanis Préau, S. Mallet, M.‐A. Richard, Jean‐Jacques Grob, René Valero, Sophie Béliard
Almmustuhtton 2015Carta -
4
On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases Dahkki C. Gaudy‐Marqueste, Romain Carron, Christine Delsanti, Anderson Loundou, S. Monestier, E. Archier, M.‐A. Richard, Jean Régis, Jean‐Jacques Grob
Almmustuhtton 2014Artigo -
5
Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibod... Dahkki B Delaloye, A. Bischof-Delaloye, F. Buchegger, V von Fliedner, Jean‐Jacques Grob, J.-C. Volant, J Pettavel, J.-P. Mach
Almmustuhtton 1986Artigo -
6
SARS‐CoV‐2 infection presenting as a febrile rash Dahkki F. Amatore, Nicolas Macagno, Morgane Mailhe, B. Demarez, C. Gaudy‐Marqueste, Jean‐Jacques Grob, Didier Raoult, Philippe Brouqui, M.‐A. Richard
Almmustuhtton 2020Carta -
7
-
8
Ara h 2 and Ara h 6 sensitization predicts peanut allergy in Mediterranean pediatric patients Dahkki C. Agabriel, Ouafeh Ghazouani, J Birnbaum, V. Liabeuf, F. Porri, M. Gouitaa, I. Cleach, Jean‐Jacques Grob, Pierre Bongrand, Jacques Sarles, Joana Vitte
Almmustuhtton 2014Artigo -
9
-
10
Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell Carcinoma Dahkki Lesley E. Rhodes, Menno A. de Rie, Ylva Enström, Richard Groves, Tore Morken, V. Goulden, Gavin Wong, Jean‐Jacques Grob, Sandeep Varma, Peter Wolf
Almmustuhtton 2004Artigo -
11
The role of BRAF V600 mutation in melanoma Dahkki Paolo A. Ascierto, John M. Kirkwood, Jean‐Jacques Grob, Ester Simeone, Antonio M. Grimaldi, Michele Maio, Giuseppe Palmieri, Alessandro Testori, Francesco M. Marincola, Nicola Mozzillo
Almmustuhtton 2012Editorial -
12
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c mela... Dahkki Josep Malvehy, Igor Samoylenko, Dirk Schadendorf, Ralf Gutzmer, Jean‐Jacques Grob, Joseph J. Sacco, Kevin Gorski, Abraham Anderson, Cheryl A. Pickett, Kate Liu, Helen Gogas
Almmustuhtton 2021Artigo -
13
Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection Dahkki C. Gaudy‐Marqueste, Yanal Wazaefi, Y. Bruneu, Raoul Triller, L. Thomas, Giovanni Pellacani, Josep Malvehy, Marie‐Françoise Avril, S. Monestier, M.‐A. Richard, Bernard Fertil, Jean‐Jacques Grob
Almmustuhtton 2017Artigo -
14
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion Dahkki Reinhard Dummer, Paolo A. Ascierto, Nicole Basset‐Séguin, Brigitte Dréno, Claus Garbe, Ralf Gutzmer, Axel Hauschild, Regina Krattinger, John T. Lear, Josep Malvehy, Dirk Schadendorf, Jean‐Jacques Grob
Almmustuhtton 2020Revisão -
15
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study Dahkki Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer, Jean‐Jacques Grob, Emel Bülbül Başkan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon L. Spector, Karin Rosén
Almmustuhtton 2014Artigo -
16
An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma Dahkki Reinhard Dummer, Axel Hauschild, Juergen C. Becker, Jean‐Jacques Grob, Dirk Schadendorf, Veronica Tebbs, Jeannine Skalsky, Katharina C. Kaehler, Stephanie Moosbauer, Ruth Clark, Tze‐Chiang Meng, Mirjana Urosevic
Almmustuhtton 2008Artigo -
17
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial Dahkki Michele Maio, Jean‐Jacques Grob, Steinar Aamdal, Igor Bondarenko, Caroline Robert, L. Thomas, Claus Garbe, Vanna Chiarion‐Sileni, Alessandro Testori, Tai‐Tsang Chen, Marina Tschaika, Jedd D. Wolchok
Almmustuhtton 2015Artigo -
18
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study Dahkki Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer, Jean‐Jacques Grob, Emel Bülbül Başkan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon L. Spector, Karin Rosén
Almmustuhtton 2014Errata/Corrigenda -
19
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline Dahkki Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Alan Spatz, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Almmustuhtton 2009Artigo -
20
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. Dahkki Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Almmustuhtton 2016Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Oncology
Cancer
Cancer research
Melanoma
Immunotherapy
Pathology
Biology
Surgery
Metastatic melanoma
Dermatology
Ipilimumab
Randomized controlled trial
Adverse effect
Nivolumab
Paleontology
Stage (stratigraphy)
Clinical trial
Confidence interval
Alternative medicine
Clinical endpoint
Placebo
Gastroenterology
Vemurafenib
Pembrolizumab
Adjuvant
Chemotherapy
Hazard ratio
Dabrafenib